Lotus BioScience Ventures
7
39M
6
0.14
4
- Areas of investment
Summary
The fund was located in Asia if to be more exact in Hong Kong. The leading representative office of defined VC is situated in the Hong Kong.
The usual cause for the fund is to invest in rounds with 7-8 partakers. Despite the Lotus BioScience Ventures, startups are often financed by Sofinnova Investments, Singapore Bio-Innovations, Alloy Ventures. The meaningful sponsors for the fund in investment in the same round are Sofinnova Investments, Singapore Bio-Innovations, MPM Capital. In the next rounds fund is usually obtained by Singapore Bio-Innovations, Sofinnova Investments, Roche Venture Fund.
The higher amount of exits for fund were in 2017. This Lotus BioScience Ventures works on 21 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The important activity for fund was in 2005. The fund is constantly included in less than 2 deals per year. The average startup value when the investment from Lotus BioScience Ventures is 5-10 millions dollars.
The fund has no exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Nereus Pharmaceuticals, Humanigen For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the most successful fund investment fields, there are Medical, Biotechnology.
Investments analytics
Analytics
- Total investments
- 7
- Lead investments
- 0
- Exits
- 4
- Follow on index
- 0.14
- Investments by industry
- Biotechnology (7)
- Health Care (5)
- Biopharma (4)
- Pharmaceutical (3)
- Medical Device (1) Show 2 more
- Investments by region
-
- United States (7)
- Peak activity year
- 2005
- Number of Minotaurs
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 20
- Avg. valuation at time of investment
- 39M
- Group Appearance index
- 1.00
- Avg. company exit year
- 19
- Avg. multiplicator
- 3.23
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Infinity Pharmaceuticals | 24 Jun 2002 | Biotechnology, Pharmaceutical, Biopharma | Early Stage Venture | 70M | United States, Cambridge, Massachusetts |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.